You can find the annual or quarterly income statement of China SXT Pharmaceuticals Inc here for insights into the performance and operational efficiency of China SXT Pharmaceuticals Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025H1

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

FY2018Q4

FY2017Q4

Total revenue

-11.72%829.49K

29.54%988.91K

-22.24%939.58K

-51.52%763.39K

17.58%1.21M

71.70%1.57M

-73.38%1.03M

-52.90%917.07K

20.07%3.86M

-37.07%1.95M

-17.93%3.22M

--3.09M

--3.92M

24.40%1.43M

--1.15M

Revenue

-11.72%829.49K

29.54%988.91K

-22.24%939.58K

-51.52%763.39K

17.58%1.21M

71.70%1.57M

-73.38%1.03M

-52.90%917.07K

20.07%3.86M

-37.07%1.95M

-17.93%3.22M

--3.09M

--3.92M

24.40%1.43M

--1.15M

Cost of revenue

6.68%694.74K

69.47%723.28K

-41.78%651.24K

-34.03%426.80K

58.96%1.12M

-28.00%646.92K

-32.31%703.72K

-17.02%898.46K

-24.44%1.04M

-6.77%1.08M

11.04%1.38M

--1.16M

--1.24M

16.52%620.68K

--532.70K

Operating expenses

-85.73%1.47M

-211.96%-5.84M

336.19%10.29M

34.80%5.22M

-39.82%2.36M

-9.47%3.87M

45.33%3.92M

39.46%4.28M

-21.51%2.70M

15.68%3.07M

32.62%3.44M

--2.65M

--2.59M

75.87%1.13M

--644.04K

Depreciation, depletion, and amortization

-33.30%68.54K

-28.32%100.50K

-6.56%102.75K

4.62%140.20K

-40.88%109.97K

-17.53%134.01K

1.68%186.00K

-18.06%162.49K

36.98%182.93K

--198.30K

--133.54K

----

103.83%29.75K

--14.60K

Operating profit

93.17%-638.27K

253.33%6.83M

-712.64%-9.35M

-93.94%-4.46M

60.21%-1.15M

31.62%-2.30M

-348.45%-2.89M

-199.98%-3.36M

627.20%1.16M

-353.16%-1.12M

-116.64%-220.75K

--442.56K

--1.33M

-40.89%300.05K

--507.65K

Net non-operating interest income (expenses)

Non-operating interest income

--17.00

--9.10K

----

242.03%236.00

-99.99%182.00

-99.83%69.00

--1.77M

--40.65K

----

Non-operating interest expense

-24.05%94.04K

99.76%136.79K

69.88%123.81K

875.47%68.48K

--72.88K

-98.84%7.02K

-100.00%0.00

--604.00K

--298.14K

----

Gains from sale of securities

58.42%-88.45K

-233.43%-80.06K

31.75%-212.71K

19.76%-24.01K

---311.64K

98.72%-29.93K

100.00%0.00

---2.34M

---184.59K

----

Special income (expenses)

----

-21.05%-422.92K

----

---349.39K

----

--0.00

----

100.00%0.00

----

---5.63M

----

Other non-operating income (expenses)

271.15%18.17K

-14.01%394.50K

-126.46%-10.62K

249.44%458.78K

-68.01%40.12K

-1241.00%-307.00K

-85.98%125.41K

79.53%-22.89K

2249.18%894.54K

-497.69%-111.85K

3969.82%38.08K

--28.13K

---984.00

-325.53%-12.05K

--5.34K

Income before tax

91.72%-802.57K

248.59%6.60M

-548.74%-9.70M

-68.07%-4.44M

45.97%-1.49M

42.03%-2.64M

-271.14%-2.77M

43.29%-4.56M

168.68%1.62M

-1831.95%-8.04M

-277.27%-2.35M

--464.01K

--1.33M

-42.62%286.73K

--499.75K

Income tax

--0.00

----

-100.00%0.00

100.55%2.37K

38.62%325.78K

-342.95%-427.70K

4649.28%235.02K

-20.43%-96.56K

-101.55%-5.17K

---80.17K

--332.41K

-16.07%104.86K

--124.94K

Income after tax

91.72%-802.57K

248.59%6.60M

-548.74%-9.70M

-67.92%-4.44M

51.66%-1.49M

35.97%-2.64M

-323.84%-3.09M

47.99%-4.13M

158.83%1.38M

-1559.04%-7.94M

-335.98%-2.35M

--544.18K

--995.05K

-51.48%181.87K

--374.81K

Net income from continuous operations

91.72%-802.57K

248.59%6.60M

-548.74%-9.70M

-67.92%-4.44M

51.66%-1.49M

35.97%-2.64M

-323.84%-3.09M

47.99%-4.13M

158.83%1.38M

-1559.04%-7.94M

-335.98%-2.35M

--544.18K

--995.05K

-51.48%181.87K

--374.81K

Net income attributable to controlling interests

91.72%-802.57K

248.59%6.60M

-548.74%-9.70M

-67.92%-4.44M

51.66%-1.49M

35.97%-2.64M

-323.84%-3.09M

47.99%-4.13M

158.83%1.38M

-1559.04%-7.94M

-335.98%-2.35M

--544.18K

--995.05K

-51.48%181.87K

--374.81K

Net income attributable to common shareholders

91.72%-802.57K

248.59%6.60M

-548.74%-9.70M

-67.92%-4.44M

51.66%-1.49M

35.97%-2.64M

-323.84%-3.09M

47.99%-4.13M

158.83%1.38M

-1559.04%-7.94M

-335.98%-2.35M

--544.18K

--995.05K

-51.48%181.87K

--374.81K

Basic earnings per share

98.72%-1.99

152.00%42.79

-32.37%-154.68

79.74%-82.30

85.31%-116.86

61.86%-406.17

-291.05%-795.36

77.59%-1.06K

125.18%416.32

-1253.48%-4.75K

-307.68%-1.65K

--412.00

--796.00

-51.46%122.56

--252.48

Diluted earnings per share

98.72%-1.99

152.00%42.79

-32.37%-154.68

79.74%-82.30

85.31%-116.86

61.86%-406.17

-291.05%-795.36

77.59%-1.06K

125.18%416.32

-1253.48%-4.75K

-307.68%-1.65K

--412.00

--796.00

-51.46%122.56

--252.48

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

